Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2026-02-25 @ 6:31 PM
Study NCT ID:
NCT03041233
Status:
COMPLETED
Last Update Posted:
2024-07-17
First Post:
2017-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ABLATOR Brazil - Ablation Observational Study (Registry)
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001281', 'term': 'Atrial Fibrillation'}], 'ancestors': [{'id': 'D001145', 'term': 'Arrhythmias, Cardiac'}, {'id': 'D006331', 'term': 'Heart Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D019370', 'term': 'Observation'}, {'id': 'D003625', 'term': 'Data Collection'}], 'ancestors': [{'id': 'D008722', 'term': 'Methods'}, {'id': 'D008919', 'term': 'Investigative Techniques'}, {'id': 'D004812', 'term': 'Epidemiologic Methods'}, {'id': 'D017531', 'term': 'Health Care Evaluation Mechanisms'}, {'id': 'D011787', 'term': 'Quality of Health Care'}, {'id': 'D017530', 'term': 'Health Care Quality, Access, and Evaluation'}, {'id': 'D011634', 'term': 'Public Health'}, {'id': 'D004778', 'term': 'Environment and Public Health'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'emily.jesser@abbott.com', 'phone': '7639541350', 'title': 'Clinical Scientist', 'organization': 'Abbott'}, 'certainAgreement': {'piSponsorEmployee': False, 'restrictiveAgreement': False}}, 'adverseEventsModule': {'timeFrame': 'Through 12 months', 'description': "An adverse event was considered when it was of cardiovascular origin with potential for the following outcomes:\n\n* Death;\n* A serious deterioration of the patient's health, which may result in: life-threatening disease/condition; permanent incapacity of a body structure/function; prolonged hospitalization; medical/surgical intervention to prevent life-threatening illness/injury; malignant tumor; planned hospitalization for a pre-existing condition was not considered a serious adverse event.", 'eventGroups': [{'id': 'EG000', 'title': 'Enrolled', 'description': 'Patients who have indication for ablation of atrial fibrillation and who were willing to provide a written consent form, except pregnant women, were included in this registry. Patients were considered enrolled in this registry at the time they signed the written consent form.', 'otherNumAtRisk': 833, 'deathsNumAtRisk': 833, 'otherNumAffected': 1, 'seriousNumAtRisk': 833, 'deathsNumAffected': 5, 'seriousNumAffected': 30}], 'otherEvents': [{'term': 'Hematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}], 'seriousEvents': [{'term': 'Hematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 5, 'numAffected': 5}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Hemothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Hematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Drowning', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Catheter Deformation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Pseudoaneurysm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 5, 'numAffected': 5}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Hematuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Pulmonary congestion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 4, 'numAffected': 4}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Chest Pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Skin lesion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Pericardial Effusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Bruise', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Car accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Tamponade', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Perioperative infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Sinus dysfunction/asystole after interruption of flutter', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Muscle abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Hemorrhagic stroke', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Prolonged Hospitalization', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Prolonged hospitalization', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Change in medical strategy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}, {'term': 'Suspected bacterial endocarditis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 833, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT'}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Unsuccessful Treatment Rate', 'denoms': [{'units': 'Participants', 'counts': [{'value': '803', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'Enrolled', 'description': 'Patients who have indication for ablation of atrial fibrillation and who were willing to provide a written consent form, except pregnant women, were included in this registry. Patients were considered enrolled in this registry at the time they signed the written consent form.'}], 'classes': [{'title': '6 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '803', 'groupId': 'OG000'}]}], 'categories': [{'measurements': [{'value': '22', 'groupId': 'OG000'}]}]}, {'title': '12 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '705', 'groupId': 'OG000'}]}], 'categories': [{'measurements': [{'value': '21', 'groupId': 'OG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'up to 6 and 12 months after ablation procedure', 'description': 'Percent of subjects with a repeat procedure', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The analysis population is subjects who received atrial fibrillation (AF) ablation for which 6-month and 12-month follow-up data was available for, respectively.'}, {'type': 'SECONDARY', 'title': 'Cardiovascular Serious Adverse Event (SAE)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '803', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'Enrolled', 'description': 'Patients who have indication for ablation of atrial fibrillation and who were willing to provide a written consent form, except pregnant women, were included in this registry. Patients were considered enrolled in this registry at the time they signed the written consent form.'}], 'classes': [{'title': '6 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '803', 'groupId': 'OG000'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}]}]}, {'title': '12 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '705', 'groupId': 'OG000'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'up to 6 and 12 months after ablation procedure', 'description': 'Percent of subjects with Cardiovascular SAE.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The analysis population is subjects who received AF ablation for which 6-month and 12-month follow-up data was available for, respectively.'}, {'type': 'SECONDARY', 'title': 'Death in Subjects Who Underwent an Ablation Procedure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '829', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'Enrolled', 'description': 'Patients who have indication for ablation of atrial fibrillation and who were willing to provide a written consent form, except pregnant women, were included in this registry. Patients were considered enrolled in this registry at the time they signed the written consent form.'}], 'classes': [{'title': 'Death <30 days post-procedure', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}]}]}, {'title': 'Death >30 days post-procedure', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'up to 12 months after ablation procedure', 'description': 'Percent of subjects experiencing death within 12 months of ablation procedure', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Enrolled', 'description': 'Patients who have indication for ablation of atrial fibrillation and who were willing to provide a written consent form, except pregnant women, were included in this registry. Patients were considered enrolled in this registry at the time they signed the written consent form.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '833'}]}, {'type': 'Procedure', 'achievements': [{'groupId': 'FG000', 'numSubjects': '829'}]}, {'type': '6-month Follow-up', 'achievements': [{'groupId': 'FG000', 'numSubjects': '803'}]}, {'type': '12-month Follow-up', 'achievements': [{'groupId': 'FG000', 'numSubjects': '705'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '801'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '32'}]}], 'dropWithdraws': [{'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '5'}]}, {'type': 'Physician Decision', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '16'}]}, {'type': 'Inclusion/Exclusion Criteria Not Met', 'reasons': [{'groupId': 'FG000', 'numSubjects': '7'}]}, {'type': 'Sponsor Request', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}]}, {'type': 'Duplicate subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}]}, {'type': 'Re-ablation', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'groups': [{'id': 'BG000', 'title': 'Enrolled', 'description': 'Patients who have indication for ablation of atrial fibrillation and who were willing to provide a written consent form, except pregnant women, were included in this registry. Patients were considered enrolled in this registry at the time they signed the written consent form.'}], 'measures': [{'title': 'Age, Customized', 'classes': [{'title': '<29 years', 'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'measurements': [{'value': '16', 'groupId': 'BG000'}]}]}, {'title': '30-39 years', 'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'measurements': [{'value': '61', 'groupId': 'BG000'}]}]}, {'title': '40-49 years', 'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'measurements': [{'value': '97', 'groupId': 'BG000'}]}]}, {'title': '50-59 years', 'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'measurements': [{'value': '220', 'groupId': 'BG000'}]}]}, {'title': '60-69 years', 'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'measurements': [{'value': '279', 'groupId': 'BG000'}]}]}, {'title': '70-79 years', 'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'measurements': [{'value': '145', 'groupId': 'BG000'}]}]}, {'title': '>80 years', 'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'measurements': [{'value': '15', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Sex: Female, Male', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '833', 'groupId': 'BG000'}]}], 'categories': [{'title': 'Female', 'measurements': [{'value': '228', 'groupId': 'BG000'}]}, {'title': 'Male', 'measurements': [{'value': '605', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race and Ethnicity Not Collected', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Race and Ethnicity were not collected from any participant.'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2017-01-20', 'size': 1870068, 'label': 'Study Protocol and Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'Prot_SAP_000.pdf', 'typeAbbrev': 'Prot_SAP', 'uploadDate': '2023-05-15T12:12', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_ONLY'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 833}, 'targetDuration': '12 Months', 'patientRegistry': True}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2017-04-13', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-07', 'completionDateStruct': {'date': '2020-04-27', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2024-07-15', 'studyFirstSubmitDate': '2017-01-24', 'resultsFirstSubmitDate': '2023-06-12', 'studyFirstSubmitQcDate': '2017-02-01', 'lastUpdatePostDateStruct': {'date': '2024-07-17', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2024-07-15', 'studyFirstPostDateStruct': {'date': '2017-02-02', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2024-07-17', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2020-04-27', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Unsuccessful Treatment Rate', 'timeFrame': 'up to 6 and 12 months after ablation procedure', 'description': 'Percent of subjects with a repeat procedure'}], 'secondaryOutcomes': [{'measure': 'Cardiovascular Serious Adverse Event (SAE)', 'timeFrame': 'up to 6 and 12 months after ablation procedure', 'description': 'Percent of subjects with Cardiovascular SAE.'}, {'measure': 'Death in Subjects Who Underwent an Ablation Procedure', 'timeFrame': 'up to 12 months after ablation procedure', 'description': 'Percent of subjects experiencing death within 12 months of ablation procedure'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Atrial Fibrillation']}, 'descriptionModule': {'briefSummary': 'The purpose of this registry is to assess the performance and clinical effectiveness of a combination of St. Jude Medical (SJM)/Abbott mapping and ablation products in the treatment of subjects with atrial fibrillation (AF).', 'detailedDescription': 'The objectives of this registry are the following:\n\n* To confirm patient safety as part of the post market surveillance study.\n* To assess performance of a combination of SJM products during procedures.\n* To assess the learning curve with a combination of SJM products.\n* To collect operator feedback on a combination of SJM products.\n\nAll patients from participating sites who are indicated for an atrial fibrillation ablation procedure and willing to provide written Informed Consent may be enrolled in this registry.\n\nIn order to ensure a minimum level of uniformity across site practices and to enable comparison of acute and long-term effectiveness as well as procedure efficiency according to technique used, a combination of 2 types of devices from the pre-specified list must be used to be eligible in this registry.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'All patients who are indicated for an atrial fibrillation ablation procedure, except for pregnant women.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* All patients who are indicated for an atrial fibrillation ablation procedure.\n\nExclusion Criteria:\n\n* Pregnant women'}, 'identificationModule': {'nctId': 'NCT03041233', 'briefTitle': 'ABLATOR Brazil - Ablation Observational Study (Registry)', 'organization': {'class': 'INDUSTRY', 'fullName': 'Abbott Medical Devices'}, 'officialTitle': 'ABLATOR Brazil - Ablation Observational Study (Registry)', 'orgStudyIdInfo': {'id': 'SJM-CIP-10192'}}, 'armsInterventionsModule': {'interventions': [{'name': 'Observation / Data Collection', 'type': 'OTHER', 'description': 'The following data will be reviewed / collected:\n\nBaseline Visit: Patient demographics; Atrial fibrillation History; Cardiovascular history; Cardiac medical history.\n\nAblation Procedure: Devices used; Ablation parameters; Ablation success definition and result; Operator feedback (Device combination chosen, device maneuverability, ease of use in combination with other device); Number, experience and type of attending personnel; Definition of standard of care (follow-up procedures and occurrence).\n\n6- and 12-month follow-up (+/- 30 DAYS): Recurrence of atrial arrhythmias: list of atrial arrhythmias since last visit, classify episodes, duration of the episodes; Changes in therapy; In case of Repeat Ablation Procedures, reconnections and new ablations will be recorded.'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Fortaleza', 'state': 'Ceará', 'country': 'Brazil', 'facility': 'Cardioritmo Eletrofisiologia e Marpasso', 'geoPoint': {'lat': -3.71722, 'lon': -38.54306}}, {'city': 'Vitória', 'state': 'Espírito Santo', 'country': 'Brazil', 'facility': 'Hospital Santa Rita', 'geoPoint': {'lat': -20.31944, 'lon': -40.33778}}, {'city': 'Vitória', 'state': 'Espírito Santo', 'country': 'Brazil', 'facility': 'Vitoria Apart Hotel', 'geoPoint': {'lat': -20.31944, 'lon': -40.33778}}, {'zip': '40050-410', 'city': 'Salvador', 'state': 'Estado de Bahia', 'country': 'Brazil', 'facility': 'Santa Casa de Misericórdia da Bahia', 'geoPoint': {'lat': -12.97563, 'lon': -38.49096}}, {'zip': '70200730', 'city': 'Brasília', 'state': 'Federal District', 'country': 'Brazil', 'facility': 'HOME - Hospital Ortopédico e Medicina Especializada LTDA.', 'geoPoint': {'lat': -15.77972, 'lon': -47.92972}}, {'city': 'Rio de Janeiro', 'state': 'Rio de Janeiro', 'country': 'Brazil', 'facility': 'Procardiaco', 'geoPoint': {'lat': -22.90642, 'lon': -43.18223}}, {'city': 'Volta Redonda', 'state': 'Rio de Janeiro', 'country': 'Brazil', 'facility': 'Unimed de Volta Redonda', 'geoPoint': {'lat': -22.52306, 'lon': -44.10417}}, {'city': 'Passo Fundo', 'state': 'Rio Grande do Sul', 'country': 'Brazil', 'facility': 'Hospital São Vicente de Paulo', 'geoPoint': {'lat': -28.26278, 'lon': -52.40667}}, {'city': 'Florianópolis', 'state': 'Santa Catarina', 'country': 'Brazil', 'facility': 'SOS Cardio', 'geoPoint': {'lat': -27.59667, 'lon': -48.54917}}, {'city': 'São José Do Rio Prêto', 'state': 'São Paulo', 'country': 'Brazil', 'facility': 'Insitituto de Moléstias Cardiovasculares - IMC'}, {'city': 'São Paulo', 'state': 'São Paulo', 'country': 'Brazil', 'facility': 'BP', 'geoPoint': {'lat': -23.5475, 'lon': -46.63611}}, {'city': 'São Paulo', 'state': 'São Paulo', 'country': 'Brazil', 'facility': 'SEMAP', 'geoPoint': {'lat': -23.5475, 'lon': -46.63611}}], 'overallOfficials': [{'name': "André Luiz D'Avila", 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'SOS Cardio'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Abbott Medical Devices', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}